Upgrade to SI Premium - Free Trial

Amphastar Pharma (AMPH) Tops Q2 EPS by 5c

August 7, 2019 5:02 PM
Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.08, $0.05 better than the analyst estimate of $0.03. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles